EMEA-002942-PIP02-20-M02

EMEA-002706-PIP01-19-M03

Opinion/decision on a Paediatric investigation plan (PIP): Vafseo, vadadustat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0290/2024

EMEA-002246-PIP01-17-M05

EMEA-001855-PIP01-15-M06

Pilot participation letter: Clinical study data proof-of-concept

Opinion/decision on a Paediatric investigation plan (PIP): Dovprela (previously Pretomanid FGK), Pretomanid, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0295/2024

Opinion/decision on a Paediatric investigation plan (PIP): Bavencio, avelumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0312/2024

EMEA-002700-PIP01-19-M02

Opinion/decision on a Paediatric investigation plan (PIP): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0284/2024